Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Oberprieler NG"'
Autor:
Oberprieler NG; Bayer AS, Oslo, Norway. niki.oberprieler@bayer.com., Pladevall-Vila M; RTI Health Solutions, Barcelona, Spain.; The Center for Health Policy and Health Services Research, Henry Ford Health System, Detroit, MI, USA., Johannes C; RTI Health Solutions, Waltham, MA, USA., Layton JB; RTI Health Solutions, Research Triangle Park, NC, USA., Golozar A; Odysseus, Inc., New York, NY, USA., Lavallee M; Odysseus, Inc., New York, NY, USA., Liu F; Bayer AG, Wuppertal, Germany., Kubin M; Bayer AG, Wuppertal, Germany., Vizcaya D; Bayer Pharmaceuticals, Sant Joan Despi, Spain.
Publikováno v:
BMC medical research methodology [BMC Med Res Methodol] 2024 Oct 01; Vol. 24 (1), pp. 224. Date of Electronic Publication: 2024 Oct 01.
Autor:
Betts KA, Oberprieler NG, Wu A, James G, Beeman S, Gay A, He X, Vizcaya D; Bayer Hispania, Avda Baix Llobregat 3-5, Sant Joan Despí 08970, Barcelona, Spain. Email: david.vizcaya@bayer.com.
Publikováno v:
The American journal of managed care [Am J Manag Care] 2024 Sep; Vol. 30 (9), pp. 405-412.
Autor:
Sato A; Department of Nephrology and Hypertension, International University of Health and Welfare Shioya Hospital, Yaita 329-2145, Japan., Rodriguez-Molina D; Integrated Evidence Generation & Business Innovation, Bayer AG, 13342 Berlin, Germany., Yoshikawa-Ryan K; Medical Affairs & Pharmacovigilance, Bayer Yakuhin Ltd., Breeze Tower, 2-4-9 Umeda, Kita-ku, Osaka 530-0001, Japan., Yamashita S; Medical Affairs & Pharmacovigilance, Bayer Yakuhin Ltd., Breeze Tower, 2-4-9 Umeda, Kita-ku, Osaka 530-0001, Japan., Okami S; Medical Affairs & Pharmacovigilance, Bayer Yakuhin Ltd., Breeze Tower, 2-4-9 Umeda, Kita-ku, Osaka 530-0001, Japan., Liu F; Integrated Evidence Generation & Business Innovation, Bayer AG, 13342 Berlin, Germany., Farjat A; Integrated Evidence Generation & Business Innovation, Bayer AG, 13342 Berlin, Germany., Oberprieler NG; Integrated Evidence Generation & Business Innovation, Bayer AG, 13342 Berlin, Germany., Kovesdy CP; Division of Nephrology, Department of Medicine, University of Tennessee Health Science Center, Memphis, TN 38163, USA., Kanasaki K; Department of Internal Medicine 1, Faculty of Medicine, Shimane University, 89-1 Enya-cho, Izumo 693-8501, Japan.; Center for Integrated Kidney Research and Advance, Faculty of Medicine, Shimane University, 89-1 Enya-cho, Izumo 693-8501, Japan., Vizcaya D; Integrated Evidence Generation & Business Innovation, Bayer AG, 13342 Berlin, Germany.
Publikováno v:
Journal of clinical medicine [J Clin Med] 2024 Aug 28; Vol. 13 (17). Date of Electronic Publication: 2024 Aug 28.
Autor:
Vizcaya D; Integrated Evidence Generation. Bayer Pharmaceuticals, Sant Joan Despí, 08970, Spain., Kovesdy CP; Division of Nephrology, University of Tennessee Health Science Center, Memphis, TN 38163, USA., Reyes A; Medical Affairs & Pharmacovigilance, Bayer Pharmaceuticals, Sant Joan Despí, 08970, Spain., Pessina E; Integrated Evidence Generation, Bayer S.p.A., Milan, 20156, Italy., Pujol P; Medical Affairs & Pharmacovigilance, Bayer Pharmaceuticals, Sant Joan Despí, 08970, Spain., James G; Integrated Evidence Generation, Bayer AG, Reading, RG2 6AD, UK., Oberprieler NG; Integrated Evidence Generation, Bayer AS, 0283 Oslo, Norway.
Publikováno v:
Journal of comparative effectiveness research [J Comp Eff Res] 2023 Aug; Vol. 12 (8), pp. e230076. Date of Electronic Publication: 2023 Jun 30.
Autor:
Oberprieler NG; Integrated Evidence Generation & Business Innovation, Bayer AS, Oslo, Norway., Farahmand B; Integrated Evidence Generation & Business Innovation, Bayer AB, Stockholm, Sweden., Cameron J; Medical Affairs, Bayer AS, Oslo, Norway., Brobert G; Integrated Evidence Generation & Business Innovation, Bayer AB, Stockholm, Sweden., Jonasson C; KG Jebsen Center for Genetic Epidemiology, Department of Public Health and Nursing, Faculty of Medicine and Health Science, NTNU-Norwegian University of Science and Technology, Trondheim, Norway., Atar D; Department of Cardiology, Oslo University Hospital Ullevål, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Publikováno v:
Fundamental & clinical pharmacology [Fundam Clin Pharmacol] 2022 Jun; Vol. 36 (3), pp. 563-571. Date of Electronic Publication: 2021 Dec 23.
Autor:
Moltu K; Centre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership, University of Oslo and Oslo University Hospital, P.O. Box 1137 Blindern, 0318 Oslo, Norway; Biotechnology Centre, University of Oslo, P.O. Box 1125 Blindern, 0317 Oslo, Norway., Henjum K; Biotechnology Centre, University of Oslo, P.O. Box 1125 Blindern, 0317 Oslo, Norway; Department of Gastrointestinal Surgery, Oslo University Hospital, P.O. Box 4956 Nydalen, 0424 Oslo, Norway., Oberprieler NG; Biotechnology Centre, University of Oslo, P.O. Box 1125 Blindern, 0317 Oslo, Norway., Bjørnbeth BA; Department of Gastrointestinal Surgery, Oslo University Hospital, P.O. Box 4956 Nydalen, 0424 Oslo, Norway., Taskén K; Centre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership, University of Oslo and Oslo University Hospital, P.O. Box 1137 Blindern, 0318 Oslo, Norway; Biotechnology Centre, University of Oslo, P.O. Box 1125 Blindern, 0317 Oslo, Norway; Department of Infectious Diseases, Oslo University Hospital, P.O. Box 4956 Nydalen, 0424 Oslo, Norway; K.G. Jebsen Centre for Cancer Immunotherapy, Biotechnology Centre, University of Oslo, P.O. Box 1125 Blindern, 0317 Oslo, Norway; K.G. Jebsen Inflammation Research Centre, Centre for Molecular Medicine Norway, University of Oslo, P.O. Box 1137 Blindern, 0318 Oslo, Norway. Electronic address: kjetil.tasken@ncmm.uio.no.
Publikováno v:
Human immunology [Hum Immunol] 2017 Feb; Vol. 78 (2), pp. 129-137. Date of Electronic Publication: 2016 Oct 18.
Autor:
Spurgeon BE; Centre for Cardiovascular and Metabolic Research, Hull York Medical School, University of Hull, Hull, UK., Aburima A, Oberprieler NG, Taskén K, Naseem KM
Publikováno v:
Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2014 Oct; Vol. 12 (10), pp. 1733-43. Date of Electronic Publication: 2014 Sep 18.
Autor:
Kalland ME; Center for Molecular Medicine, Nordic European Molecular Biology Laboratory Partnership, University of Oslo, N-0318 Oslo, Norway., Oberprieler NG, Vang T, Taskén K, Torgersen KM
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2011 Nov 15; Vol. 187 (10), pp. 5233-45. Date of Electronic Publication: 2011 Oct 19.
Autor:
Oberprieler NG; The Biotechnology Centre of Oslo and Centre for Molecular Medicine, Nordic EMBL Partnership, University of Oslo, Oslo, Norway., Taskén K
Publikováno v:
Cellular signalling [Cell Signal] 2011 Jan; Vol. 23 (1), pp. 14-8. Date of Electronic Publication: 2010 Jul 16.
Autor:
Oberprieler NG; The Biotechnology Centre of Oslo and Centre for Molecular Medicine, Nordic EMBL Partnership, University of Oslo, Blindern, Oslo, Norway., Lemeer S, Kalland ME, Torgersen KM, Heck AJ, Taskén K
Publikováno v:
Blood [Blood] 2010 Sep 30; Vol. 116 (13), pp. 2253-65. Date of Electronic Publication: 2010 Jun 17.